Tenable (TENB) Insider Sale Notice — 1,261 Shares from Restricted Vesting
Rhea-AI Filing Summary
Tenable Holdings, Inc. (TENB) Form 144 reports a proposed sale of 1,261 shares of common stock to be executed through Fidelity Brokerage Services on 08/25/2025 on NASDAQ, with an aggregate market value of $38,149.42. The filer states total shares outstanding of 121,094,958. The shares were acquired on 08/22/2025 through restricted stock vesting from the issuer and the payment nature is listed as compensation.
The filing also discloses recent insider sales by related persons during the past three months: James B. Anschutz sold 655 shares on 05/27/2025 (gross proceeds $21,254.29) and 970 shares on 07/17/2025 (gross proceeds $32,087.60); Stephen Vintz sold 3,386 shares on 05/27/2025 (gross proceeds $109,873.33); Bridgett Paradise sold 1,518 shares on 05/27/2025 (gross proceeds $49,258.04). The form includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider sale notice; small volume relative to shares outstanding, likely non-material to market.
The Form 144 indicates a planned sale of 1,261 vested restricted shares with an aggregate value of $38,149.42, executed via a broker on NASDAQ. Compared with the reported 121,094,958 shares outstanding, this position represents a de minimis fraction of the float. Recent related-party sales shown in the filing total several thousand shares across late May and mid-July 2025, with gross proceeds reported. There is no earnings, debt, or operational data in the filing to suggest a material corporate event. The disclosure fulfills Rule 144 notice requirements and provides transparency about insider liquidity events.
TL;DR: Filing documents insider vesting and planned disposition; looks like routine compliance with Rule 144.
The record shows the securities were acquired by restricted stock vesting and are being sold as compensation proceeds, which is common for executives or employees realizing vested equity. The inclusion of recent sales by named individuals and the standard signature representation supports regulatory compliance. The form does not indicate any undisclosed material adverse information per the signer’s declaration. No governance red flags or unusual transfer structures are evident from the data provided.